137 related articles for article (PubMed ID: 2898463)
1. Defective human immunodeficiency virus (HIV) particles produced by cloned cells of HTLV-I-carrying MT-4 cells persistently infected with HIV.
Ikuta K; Morita C; Nakai M; Yamamoto N; Kato S
Jpn J Cancer Res; 1988 Apr; 79(4):418-23. PubMed ID: 2898463
[TBL] [Abstract][Full Text] [Related]
2. Production of infectious particles from defective human immunodeficiency virus type 1 (HIV-1)-producing cell clones by superinfection with infectious HIV-1.
Yunoki M; Maotani-Imai K; Kusuda H; Motoyama M; Miyake S; Imai H; Shin YS; Kato S; Sano K; Morita C
Arch Virol; 1991; 116(1-4):143-58. PubMed ID: 2001175
[TBL] [Abstract][Full Text] [Related]
3. A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB.
Albert J; Bredberg U; Chiodi F; Böttiger B; Fenyö EM; Norrby E; Biberfeld G
AIDS Res Hum Retroviruses; 1987; 3(1):3-10. PubMed ID: 3040053
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of fusion receptors for human T-cell leukemia virus type-I (HTLV-I) and human immunodeficiency virus type-1 (HIV-1) on MOLT-4 cells.
Kannagi M; Kuroda MJ; Maeda Y; Harada S
Microbiol Immunol; 1991; 35(9):729-40. PubMed ID: 1687290
[TBL] [Abstract][Full Text] [Related]
5. Noninfectious doughnut-shaped human immunodeficiency virus type 1 can induce syncytia mediated by fusion of the particles with CD4-positive cells.
Ohki K; Kishi Y; Nishino Y; Sumiya M; Kimura T; Goto T; Nakai M; Ikuta K
J Acquir Immune Defic Syndr (1988); 1991; 4(12):1233-40. PubMed ID: 1682474
[TBL] [Abstract][Full Text] [Related]
6. Biological characterization of a simian immunodeficiency virus-like retrovirus (HTLV-IV): evidence for CD4-associated molecules required for infection.
Hoxie JA; Haggarty BS; Bonser SE; Rackowski JL; Shan H; Kanki PJ
J Virol; 1988 Aug; 62(8):2557-68. PubMed ID: 2839686
[TBL] [Abstract][Full Text] [Related]
7. The budding of defective human immunodeficiency virus type 1 (HIV-1) particles from cell clones persistently infected with HIV-1.
Goto T; Ikuta K; Zhang JJ; Morita C; Sano K; Komatsu M; Fujita H; Kato S; Nakai M
Arch Virol; 1990; 111(1-2):87-101. PubMed ID: 1691624
[TBL] [Abstract][Full Text] [Related]
8. Infection of human T-lymphotropic virus type-I (HTLV-I)-bearing MT-4 cells with HTLV-III (AIDS virus): chronological studies of early events.
Harada S; Koyanagi Y; Yamamoto N
Virology; 1985 Oct; 146(2):272-81. PubMed ID: 2413616
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the safety of blood products with respect to human immunodeficiency virus infection by using an HTLV-I-infected cell line (SKT-1B).
Koito A; Shirono K; Suto H; Matsushita S; Hattori T; Takatsuki K
Jpn J Cancer Res; 1987 Apr; 78(4):365-71. PubMed ID: 2884206
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of human immunodeficiency virus type 1 infectivity by replacing the region including Env derived from defective particles with an ability to form particle-mediated syncytia in CD4+T cells.
Kinomoto M; Mukai T; Li YG; Iwabu Y; Warachit J; Palacios JA; Ibrahim MS; Tsuji S; Goto T; Ikuta K
Microbes Infect; 2004 Aug; 6(10):911-8. PubMed ID: 15310467
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructure and morphogenesis of human immunodeficiency virus.
Nakai M; Goto T
J Electron Microsc (Tokyo); 1996 Aug; 45(4):247-57. PubMed ID: 8888583
[TBL] [Abstract][Full Text] [Related]
12. Substances affecting the infection and replication of human immunodeficiency virus (HIV).
Yamamoto N; Harada S; Nakashima H
AIDS Res; 1986 Dec; 2 Suppl 1():S183-9. PubMed ID: 3030346
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructure of human retroviruses.
Palmer E; Goldsmith CS
J Electron Microsc Tech; 1988 Jan; 8(1):3-15. PubMed ID: 2854553
[TBL] [Abstract][Full Text] [Related]
14. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
McDougal JS; Mawle A; Cort SP; Nicholson JK; Cross GD; Scheppler-Campbell JA; Hicks D; Sligh J
J Immunol; 1985 Nov; 135(5):3151-62. PubMed ID: 2995487
[TBL] [Abstract][Full Text] [Related]
15. Tumor promoter, TPA, enhances replication of HTLV-III/LAV.
Harada S; Koyanagi Y; Nakashima H; Kobayashi N; Yamamoto N
Virology; 1986 Oct; 154(2):249-58. PubMed ID: 3639669
[TBL] [Abstract][Full Text] [Related]
16. Human retroviruses: a decade of discovery and link with human disease.
Gallo RC
J Infect Dis; 1991 Aug; 164(2):235-43. PubMed ID: 1677372
[No Abstract] [Full Text] [Related]
17. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)].
Ito M; Nakashima H; Baba M; Pauwels R; De Clercq E; Shigeta S; Yamamoto N
Antiviral Res; 1987 Mar; 7(3):127-37. PubMed ID: 3475037
[TBL] [Abstract][Full Text] [Related]
18. Polymorphic Nature of Human T-Cell Leukemia Virus Type 1 Particle Cores as Revealed through Characterization of a Chronically Infected Cell Line.
Meissner ME; Mendonça LM; Zhang W; Mansky LM
J Virol; 2017 Aug; 91(16):. PubMed ID: 28615198
[TBL] [Abstract][Full Text] [Related]
19. Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I.
De Rossi A; Franchini G; Aldovini A; Del Mistro A; Chieco-Bianchi L; Gallo RC; Wong-Staal F
Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4297-301. PubMed ID: 2424024
[TBL] [Abstract][Full Text] [Related]
20. A unique human immunodeficiency virus culture secreting soluble gp160.
Kalyanaraman VS; Pal R; Gallo RC; Sarngadharan MG
AIDS Res Hum Retroviruses; 1988 Oct; 4(5):319-29. PubMed ID: 3264172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
